1. Generics Bulletin

Japan Approves Biosimilar Teriparatide And Darbepoetin

 
• By Aidan Fry

Japan’s first biosimilar teriparatide has been approved for Mochida Pharmaceutical, while competition in the darbepoetin alfa arena looks set to step up following two recent authorizations.

Bone_Structure
Mochida says it has received Japan's first approval for a biosimilar version of the osteoporosis drug teriparatide • Source: Shutterstock

Mochida Pharmaceutical says it has received the first approval for biosimilar teriparatide issued by Japan’s Ministry of Health, Labor and Welfare. At around the same time, Gene Techno Science and JCR Pharmaceuticals each announced they had received authorizations for darbepoetin alfa biosimilars.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Biosimilars

More from Products